Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Ipsen secures NICE approval for multi-targeting kidney cancer therapy

July 11, 2017 Manufacturing and Production, Sales and Marketing Cabometyx, Kidney cancer, NICE

Ipsen has announced that its therapy Cabometyx (cabozantinib) has been given approval by NICE for the treatment of advanced renal …
News

ABPI launches legal action to overturn £20m price cap

July 11, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE

When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
News
brenda-fitzgerald-2

New director of CDC courts controversy from all angles

July 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US

It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …
Appointment
shutterstock_339308225

Revealing the missing evidence: Randomised real-life studies in basal insulin therapy

July 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
Feature

Endo withdraws product as FDA secures step in opioid crisis fightback

July 10, 2017 Sales and Marketing Endo pharmaceuticals, FDA, Opana ER

The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …
News
shutterstock_2

Problematic facility inspection puts Biocon’s biosimilar EU approvals on hold

July 10, 2017 Manufacturing and Production, Sales and Marketing Biocon, India, biosimilars

Indian firm Biocon has been hit by regulator criticism which has forced its European biosimilar programme on hold following a …
News
shire_image

Shire and Roche haemophilia spat spills into court

July 10, 2017 Sales and Marketing Roche, Shire, haemophilia

Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …
News
brexit_flag

European pharma pulls together to ensure ‘minimal disruption’ from Brexit

July 10, 2017 Research and Development, Sales and Marketing EMA, Europe, UK

As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …
News
sickle_cells

FDA gives go-ahead to first sickle cell treatment in 20 years

July 10, 2017 Sales and Marketing Emmaus Medical, L-glutamine, sickle cell disease

Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …
News
gagan_singh

AstraZeneca appoint new MD for India

July 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India

AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
Appointment
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

July 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …
News
celgene_1_02

Celgene plays catch up with $1.4 billion immunotherapy deal

July 7, 2017 Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …
News
shutterstock_138095450

New data shows pharma has not cut back on controversial payments to physicians

July 6, 2017 Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
News
ob_logo

Oxford BioMedica in $100 million manufacturing deal with Novartis

July 6, 2017 Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica

Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …
News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017 Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026